FTSJD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.20629950473017E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.40569999979223E-08 |
Normal-vs-Stage2 |
3.357100E-04 |
Normal-vs-Stage3 |
1.96909999417016E-09 |
Normal-vs-Stage4 |
5.3786974874015E-12 |
Stage1-vs-Stage2 |
7.600800E-01 |
Stage1-vs-Stage3 |
2.078000E-02 |
Stage1-vs-Stage4 |
6.825300E-04 |
Stage2-vs-Stage3 |
2.874400E-01 |
Stage2-vs-Stage4 |
7.953500E-02 |
Stage3-vs-Stage4 |
2.942800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.74919975673527E-10 |
Normal-vs-AfricanAmerican |
3.83660000435881E-08 |
Normal-vs-Asian |
1.357790E-01 |
Caucasian-vs-AfricanAmerican |
4.149000E-01 |
Caucasian-vs-Asian |
4.125800E-01 |
AfricanAmerican-vs-Asian |
2.334400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.80577816325467E-12 |
Normal-vs-Female |
1.17079999994996E-06 |
Male-vs-Female |
9.698400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.46110000554378E-08 |
Normal-vs-Age(41-60Yrs) |
3.57389999816604E-08 |
Normal-vs-Age(61-80Yrs) |
8.42199976425206E-10 |
Normal-vs-Age(81-100Yrs) |
2.360700E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.818400E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.221700E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.705980E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.488200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.793800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.711600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.084280E-02 |
Normal-vs-Grade 2 |
6.93279999963714E-07 |
Normal-vs-Grade 3 |
2.03560501788047E-11 |
Normal-vs-Grade 4 |
1.68431935065882E-12 |
Grade 1-vs-Grade 2 |
9.252200E-01 |
Grade 1-vs-Grade 3 |
4.979200E-01 |
Grade 1-vs-Grade 4 |
4.714500E-02 |
Grade 2-vs-Grade 3 |
4.277500E-02 |
Grade 2-vs-Grade 4 |
2.34539999999228E-05 |
Grade 3-vs-Grade 4 |
5.743500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.57180000000579E-05 |
Normal-vs-ccB subtype |
5.65860025503184E-10 |
ccA subtype-vs-ccB subtype |
7.808300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.10389999977245E-07 |
Normal-vs-N1 |
4.07070000000287E-05 |
N0-vs-N1 |
1.704590E-01 |
|
|